Cancer pharmacogenomics: implications on ethnic diversity and drug response

Pharmacogenetics and Genomics
Jai N Patel

Abstract

The goal of pharmacogenomic research is to discover and validate genetic variants that are predictive of drug response, for eventual implementation into clinical practice. Cancer pharmacogenomics provides the opportunity to analyze two sets of DNA, that of the tumor (somatic) and that of the host (germline). Germline variants are inherited variations and are often associated with the pharmacokinetic behavior of a drug, including drug disposition and ultimately drug efficacy and/or toxicity, whereas somatic mutations are often useful in predicting the pharmacodynamic response to drugs. Pharmacoethnicity, or ethnic diversity in drug response or toxicity, is an increasingly recognized factor accounting for interindividual variations in anticancer drug response. Pharmacoethnicity is often determined by germline pharmacogenomic factors and the distribution of single nucleotide polymorphisms across various populations, but it may also be influenced by nongenetic factors, such as environmental factors. This review aims to elucidate the importance of pharmacoethnicity in cancer pharmacogenomic research and implementation, focusing solely on germline variants.

References

Jan 1, 1992·Clinical Pharmacology and Therapeutics·B KlemetsdalJ Aarbakke
Jan 1, 1994·Clinical Pharmacology and Therapeutics·H L McLeodW E Evans
Feb 5, 1999·Human Molecular Genetics·M M AmeyawH L McLeod
Dec 2, 1999·Journal of the National Cancer Institute·M V RellingW E Evans
Aug 8, 2002·Journal of the National Cancer Institute·A David McCollumCharles S Fuchs
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thierry LecomtePierre Laurent-Puig
Jan 6, 2005·Journal of the National Cancer Institute·Yan JinDavid A Flockhart
Feb 1, 2005·World Journal of Gastroenterology : WJG·May-Jen HuangChing-Shan Huang
Mar 24, 2005·JAMA : the Journal of the American Medical Association·Martin StanullaMatthias Schwab
Apr 19, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jean-Nicholas RoyMichel Roger
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuyuki KawakamiMauro Magnani
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lori Kay MattisonRobert B Diasio
May 1, 2007·Pharmacogenomics·Giuseppe Toffoli, Erika Cecchin
Aug 31, 2007·Journal of the National Cancer Institute·Janelle M HoskinsHoward L McLeod
Dec 19, 2007·Pediatric Blood & Cancer·Jamie L RenbargerStephen D Hall
Feb 27, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthias SchwabUNKNOWN German 5-FU Toxicity Study Group
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel G HallerChris Twelves
Jul 11, 2008·Clinical Pharmacology and Therapeutics·S U YasudaS-M Huang
Jul 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter H O'Donnell, M Eileen Dolan
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ToffoliFederico Innocenti
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kazuma KiyotaniHitoshi Zembutsu
Jun 3, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Werner SchrothHiltrud Brauch
Dec 17, 2010·World Journal of Gastrointestinal Surgery·Shouji Shimoyama
Jan 29, 2011·Clinical Pharmacology and Therapeutics·M V RellingUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Mar 25, 2011·Clinical Pharmacology and Therapeutics·L MadlenskyJ P Pierce
Jun 23, 2011·Pharmacogenomics·Mary W RoedererUNKNOWN Pharmacogenetics for Every Nation Initiative
Apr 26, 2012·The Oncologist·Daniel L HertzWilliam J Irvin
Oct 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiltrud BrauchMichel Eichelbaum
Jan 29, 2013·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jai N PatelHoward L McLeod
Jul 11, 2013·Pharmacogenomics·Jai N PatelHoward L McLeod
Dec 18, 2013·Pharmacogenomics·Jai N Patel
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dan RosmarinIan Tomlinson
Jun 14, 2014·Journal of the National Cancer Institute·Wen-Qing LiMitchell H Gail

❮ Previous
Next ❯

Citations

Jun 20, 2015·Frontiers in Genetics·Luis A Quiñones, Kuen S Lee
Aug 5, 2016·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Yeon Hee ParkKyung Hae Jung
Sep 13, 2019·Expert Opinion on Drug Metabolism & Toxicology·Giuseppe MiscioDavide Seripa
Dec 20, 2017·Drug Metabolism and Personalized Therapy·Carlos A Castro-RojasAugusto Rojas-Martinez
Sep 20, 2018·Scientific Reports·Santiago GuerreroCésar Paz-Y-Miño
Apr 22, 2016·Clinical and Experimental Pharmacology & Physiology·Shu-Ting PanShu-Feng Zhou
Jan 1, 2018·JCO Precision Oncology·Daniel L HertzArul Chinnaiyan
Dec 22, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ChandraniA Dutt
Jul 13, 2021·British Journal of Clinical Pharmacology·Emma F MagavernSandra Soo-Jin Lee
Sep 22, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Stephen SonisFredrick D Ashbury

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

PGENI

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Peter H O'Donnell, M Eileen Dolan
Current Drug Discovery Technologies
Jeffrey Wang, Ying Huang
Expert Opinion on Drug Metabolism & Toxicology
Viet Hong PhanStephen J Clarke
Trends in Pharmacological Sciences
William P Petros, W E Evans
© 2022 Meta ULC. All rights reserved